...
首页> 外文期刊>Brain, Behavior, and Immunity >Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-beta in an APP transgenic mouse model
【24h】

Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-beta in an APP transgenic mouse model

机译:生长激素释放激素对APP转基因小鼠模型睡眠和脑间质淀粉样β的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by impairment of cognitive function, extracellular amyloid plaques, intracellular neurofibrillary tangles, and synaptic and neuronal loss. There is substantial evidence that the aggregation of amyloid beta (A beta) in the brain plays a key role in the pathogenesis of AD and that A beta aggregation is a concentration dependent process. Recently, it was found that A beta levels in the brain interstitial fluid (ISF) are regulated by the sleep-wake cycle in both humans and mice; ISF A beta is higher during wakefulness and lower during sleep. Intracerebroventricular infusion of orexin increased wakefulness and ISF A beta levels, and chronic sleep deprivation significantly increased A beta plague formation in amyloid precursor protein transgenic (APP) mice. Growth hormone-releasing hormone (GHRH) is a well-documented sleep regulatory substance which promotes non-rapid eye movement sleep. GHRHR(lit/lit) mice that lack functional GHRH receptor have shorter sleep duration and longer wakefulness during light periods. The current study was undertaken to determine whether manipulating sleep by interfering with GHRH signaling affects brain ISF A beta levels in APPswe/PS1 Delta E9 (PSIAPP) transgenic mice that overexpress mutant forms of APP and PSENI that cause autosomal dominant AD. We found that intraperitoneal injection of GHRH at dark onset increased sleep and decreased ISF A beta and that delivery of a GHRH antagonist via reverse-microdialysis suppressed sleep and increased ISF A beta. The diurnal fluctuation of ISF A beta in PS1APP/GHRHR(lit/lit) mice was significantly smaller than that in PSIAPP/GHRHR(lit/+) mice. However despite decreased sleep in GHRHR deficient mice, this was not associated with an increase in A beta accumulation later in life. One of several possibilities for the finding is the fact that GHRHR deficient mice have GHRH-dependent but sleep-independent factors which protect against A beta deposition. (C) 2014 Elsevier Inc. All rights reserved.
机译:阿尔茨海默氏病(AD)是一种神经退行性疾病,其特征在于认知功能受损,细胞外淀粉样斑块,细胞内神经原纤维缠结以及突触和神经元丢失。有大量证据表明,大脑中淀粉样蛋白β(A beta)的聚集在AD的发病机理中起着关键作用,并且Aβ聚集是一种浓度依赖性过程。最近发现,人类和小鼠的大脑觉醒周期都调节着大脑间质液(ISF)中的Aβ水平。 ISF A beta在清醒时较高,在睡眠时较低。脑室内注入orexin增加觉醒和ISF A beta水平,而长期睡眠剥夺则明显增加淀粉样前体蛋白转基因(APP)小鼠的A beta鼠疫形成。生长激素释放激素(GHRH)是一种有据可查的睡眠调节物质,可促进非快速眼动睡眠。缺少功能性GHRH受体的GHRHR(lit / lit)小鼠在短时间内睡眠时间较短,清醒时间较长。本研究旨在确定通过干扰GHRH信号来操纵睡眠是否影响过表达导致常染色体显性AD的APP和PSENI突变形式的APPswe / PS1 Delta E9(PSIAPP)转基因小鼠的大脑ISF A beta水平。我们发现在黑暗发作时腹腔注射GHRH会增加睡眠并降低ISF A beta,而通过逆向微透析递送GHRH拮抗剂会抑制睡眠并增加ISF A beta。 PS1APP / GHRHR(lit / lit)小鼠的ISF A beta的昼夜波动明显小于PSIAPP / GHRHR(lit / +)小鼠。然而,尽管缺乏GHRHR的小鼠睡眠减少,但这与以后生活中Aβ积累的增加无关。该发现的几种可能性之一是事实,即缺乏GHHRR的小鼠具有GHRH依赖性但与睡眠无关的因子,可防止Aβ沉积。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号